|
2024
|
Invention
|
Monoclonal antibody against nerve growth factor, and encoding gene and use thereof.
The present ... |
|
|
Invention
|
Anti-pd-1/vegfa bifunctional antibody, pharmaceutical composition thereof and use thereof.
The p... |
|
|
Invention
|
Pharmaceutical combination and use. Provided are a pharmaceutical combination and a use. The phar... |
|
|
Invention
|
Compound and antibody-drug conjugate comprising same. Provide are a compound and an antibody-drug... |
|
|
Invention
|
Bispecific antibody, pharmaceutical composition, and use. A bispecific antibody, a pharmaceutical... |
|
|
Invention
|
Anti-lag3 antibody, pharmaceutical composition, and use. The present invention relates to an anti... |
|
|
Invention
|
Fusion protein comprising tgf-βrii extracellular region fragment, pharmaceutical composition ther... |
|
2023
|
Invention
|
Bispecific antibody containing anti-cldn18.2 antibody, and pharmaceutical composition and use the... |
|
|
Invention
|
Anti-cldn18.2 antibody, and pharmaceutical composition and use thereof. Provided are an anti-CLDN... |
|
|
Invention
|
Therapeutic combination and use thereof.
The present invention belongs to the field of tumor tre... |
|
|
Invention
|
Pharmaceutical composition and use thereof. Disclosed herein are a pharmaceutical composition and... |
|
|
Invention
|
Anti-pd-1/vegfa bifunctional antibody, pharmaceutical composition thereof. The present applicatio... |
|
|
Invention
|
Anti-human il-4ra antibody and application thereof. The present invention relates to an anti-huma... |
|
|
Invention
|
Pharmaceutical composition and use thereof.
The present invention relates to a pharmaceutical co... |
|
|
Invention
|
Pharmaceutical composition and use thereof. The present invention relates to a pharmaceutical com... |
|
|
Invention
|
Pharmaceutical composition comprising anti-tigit antibody and anti-pd-1/anti-vegfa bispecific ant... |
|
|
Invention
|
Pharmaceutical composition comprising anti-tigit antibody and anti-pd-1-anti-vegfa bispecific ant... |
|
2022
|
Invention
|
Anti-lag3 bispecific antibody, pharmaceutical composition and use. Provided are an anti-LAG3 anti... |
|
|
Invention
|
Anti-lag3 antibody, pharmaceutical composition and use.
The present invention belongs to the fie... |
|
|
Invention
|
Anti-lag3 antibody, pharmaceutical composition and use. The present invention belongs to the fiel... |
|
|
Invention
|
Fusion protein containing anti-tigit antibody and tgf-ßr, and pharmaceutical composition and use ... |
|
|
Invention
|
Fusion protein containing anti-tigit antibody and tgf-βr, and pharmaceutical composition and use ... |
|
|
Invention
|
Pharmaceutical composition and use.
A pharmaceutical composition comprising an anti-TIGIT antibo... |
|
|
Invention
|
Pharmaceutical composition and use. A pharmaceutical composition comprising an anti-TIGIT antibod... |
|
|
Invention
|
Anti-cd47 monoclonal antibody and use thereof. An anti-CD47 monoclonal antibody and the use there... |
|
|
Invention
|
Anti-ctla4 monoclonal antibody or its antigen binding fragments, pharmaceutical compositions and ... |
|
|
Invention
|
Method for improving safety of drug containing immunoglobulin fc fragment. Provided is a method f... |
|
|
Invention
|
Pharmaceutical combination containing anti-pd-1-anti-vegfa bispecific antibody, and use thereof. ... |
|
2021
|
Invention
|
Anti-tigit antibody, and pharmaceutical composition and use thereof.
An ant-TIGIT antibody, and ... |
|
|
Invention
|
Anti-tigit antibody, and pharmaceutical composition and use thereof. An anti-TIGIT antibody, and ... |
|
|
Invention
|
Anti-cd73 antibody and use thereof.
An anti-CD73 antibody and the use thereof. The heavy chain v... |
|
|
Invention
|
Anti-cd73 antibody and use thereof. An anti-CD73 antibody and the use thereof. The heavy chain va... |
|
|
Invention
|
Anti-cd73 antibody and use thereof.
The present disclosure relates to an anti-CD73 antibody and ... |
|
|
Invention
|
Anti-cd73 antibody and use thereof. Provided are an anti-CD73 antibody and an application thereof... |
|
|
Invention
|
Anti-cd73 antibody and use thereof.
Provided in the present invention are an anti-CD73 antibody ... |
|
|
Invention
|
Anti-cd73-anti-pd-1 bispecific antibody and use thereof.
Provided are an anti-CD73-anti-PD-1 bis... |
|
|
Invention
|
Anti-cd73 antibody and use thereof. Provided in the present invention are an anti-CD73 antibody a... |
|
|
Invention
|
Anti-cd73-anti-pd-1 bispecific antibody and use thereof. Provided are an anti-CD73-anti-PD-1 bisp... |
|
|
Invention
|
Anti-il-1β antibody, and pharmaceutical composition containing same, and use thereof. Disclosed i... |
|
|
Invention
|
Anti-cd73 antibody and use thereof. The present invention relates to an anti-CD73 antibody and th... |
|
2020
|
Invention
|
Anti-pd-1-anti-vegfa bispecific antibody, pharmaceutical composition and use thereof.
Provided a... |
|
|
Invention
|
Anti-pd-1-anti-vegfa bispecific antibody, pharmaceutical composition and use thereof. Provided ar... |
|
|
Invention
|
Anti-cd47 monoclonal antibody and use thereof.
Provided are an anti-CD47 monoclonal antibody and... |
|
|
Invention
|
Anti-human p40 protein domain antibody and use thereof.
Provided is an antibody for the treatmen... |
|
2019
|
Invention
|
Antibody against human il-4ra and use thereof.
The present invention relates to an anti-human in... |
|
|
Invention
|
Anti-il-1β antibody and pharmaceutical composition thereof and use of same. The present invention... |
|
|
Invention
|
Anti-vegf-pd1 bispecific antibody with novel structure and use thereof. The disclosure relates to... |
